Midatech Pharma PLC CEO and leadership

Stephen Stamp is responsible for all financial matters at Assurex Health, including financing strategy and implementation, accounting, tax, mergers & acquisitions, and government contracting. Stephen brings to Assurex Health nearly 30 years of experience in finance, accounting, business development and operations. He has worked in multiple public and venture-backed companies both in the US and the UK, including business to consumer (B2C), business to business (B2B), and pharmaceutical industries. Stephen has served as Chief Financial Officer of EZCORP, Inc., a publicly-traded consumer financial services company; Chief Operating Officer, Chief Financial Officer, and Executive Vice President Business Development at Xanodyne Pharmaceuticals, Inc., a specialty pharmaceutical company; Group Finance Director at Regus PLC, a publicly-traded company that provides serviced office accommodations in business centers worldwide; and as Group Finance Director at Shire PLC, a publicly-traded UK specialty pharmaceutical company focused on ADHD and other specialty medications. Earlier in his career, Stephen was an investment banker with Lazard in London and worked for KPMG, also in London, where he qualified as a Chartered Accountant. Stephen received his BA in economics from the University of Manchester.

Stephen Stamp is responsible for all financial matters at Assurex Health, including financing strategy and implementation, accounting, tax, mergers & acquisitions, and government contracting. Stephen brings to Assurex Health nearly 30 years of experience in finance, accounting, business development and operations. He has worked in multiple public and venture-backed companies both in the US and the UK, including business to consumer (B2C), business to business (B2B), and pharmaceutical industries. Stephen has served as Chief Financial Officer of EZCORP, Inc., a publicly-traded consumer financial services company; Chief Operating Officer, Chief Financial Officer, and Executive Vice President Business Development at Xanodyne Pharmaceuticals, Inc., a specialty pharmaceutical company; Group Finance Director at Regus PLC, a publicly-traded company that provides serviced office accommodations in business centers worldwide; and as Group Finance Director at Shire PLC, a publicly-traded UK specialty pharmaceutical company focused on ADHD and other specialty medications. Earlier in his career, Stephen was an investment banker with Lazard in London and worked for KPMG, also in London, where he qualified as a Chartered Accountant. Stephen received his BA in economics from the University of Manchester.